Orexin and Alzheimer’s Disease: A New Perspective

키워드

참고문헌 (80)

1. Willie JT, "To eat or to sleep? Orexin in the regulation of feeding and wakefulness", Annu Rev Neurosci, 24, pp.429~458 (2001)
2. Burdakov D, "How orexin signals bias action : hypothalamic and accumbal circuits", Brain Res, 1731, pp.145943~ (2020)
3. Mavanji V, "Promotion of wakefulness and energy expenditure by orexin-A in the ventrolateral preoptic area", Sleep, 38, pp.1361~1370 (2015)
4. Prober DA, "Discovery of hypocretin", orexin ushers in a new era of sleep research, 2018, pp.41, 70~72
5. Soya S, "Orexin as a modulator of fear-related behavior : hypothalamic control of noradrenaline circuit", Brain Res, 1731, pp.146037~ (2020)
6. Summers CH, "Orexin", hypocretin receptor modulation of anxiolytic and antidepressive responses during social stress and decision-making : Potential for therapy, 2020, pp.1731, 146085~
7. Burdakov D, "Reactive and predictive homeostasis : roles of orexin", hypocretin neurons, 2019, pp.154, 61~67
8. Song J, "The role of orexin in post-stroke inflammation, cognitive decline, and depression", Mol Brain, 8, pp.16~ (2015)
9. Chen Q, "The hypocretin", orexin system : an increasingly important role in neuropsychiatry, 2015, pp.35, 152~197
10. Grafe LA, "Orexins and stress", Front Neuroendocrinol, 51, pp.132~145 (2018)
11. Ji MJ, "Orexin prevents depressivelike behavior by promoting stress resilience", Mol Psychiatry, 24, pp.282~293 (2019)
12. Sargin D, "The role of the orexin system in stress response", Neuropharmacology, 154, pp.68~78 (2019)
13. Eacret D, "Orexin signaling during social defeat stress influences subsequent social interaction behaviour and recognition memory", Behav Brain Res, 356, pp.444~452 (2019)
14. Bahramzadeh Zoeram S, "Hippocampal orexin receptor blocking prevented the stress induced social learning and memory deficits", Neurobiol Learn Mem, 157, pp.12~23 (2019)
15. Grafe LA, "Orexins mediate sex differences in the stress response and in cognitive flexibility", Biol Psychiatry, 81, pp.683~692 (2017)
16. Al-Barazanji KA, "Central orexin-A activates hypothalamic-pituitary-adrenal axis and stimulates hypothalamic corticotropin releasing factor and arginine vasopressin neurones in conscious rats", J Neuroendocrinol, 13, pp.421~424 (2001)
17. Chang H, "Inhibitory effects of an orexin-2 receptor antagonist on orexin A-and stress-induced ACTH responses in conscious rats", Neurosci Res, 57, pp.462~466 (2007)
18. Grafe LA, "Reduced orexin system function contributes to resilience to repeated social stress", eNeuro, 5 (2018)
19. Gozzi A, "Differential effect of orexin-1 and CRF-1 antagonism on stress circuits : a fMRI study in the rat with the pharmacological stressor Yohimbine", Neuropsychopharmacology, 38, pp.2120~2130 (2013)
20. Walling SG, "Orexin-A infusion in the locus ceruleus triggers norepinephrine(NE)release and NE-induced long-term potentiation in the dentate gyrus", J Neurosci, 24, pp.7421~7426 (2004)
21. Ardeshiri MR, "Orexin 1 and orexin 2 receptor antagonism in the basolateral amygdala modulate long-term potentiation of the population spike in the perforant path-dentate gyrus-evoked field potential in rats", Neurobiol Learn Mem, 149, pp.98~106 (2018)
22. Shi L, "Orexin A differentially influences the extinction retention of recent and remote fear memory", Front Neurosci, 12, pp.295~ (2018)
23. Dang R, "Orexin knockout mice exhibit impaired spatial working memory", Neurosci Lett, 668, pp.92~97 (2018)
24. Akbari E, "The selective orexin 1 receptor antagonist SB-334867-A impairs acquisition and consolidation but not retrieval of spatial memory in Morris water maze", Peptides, 28, pp.650~656 (2007)
25. Baykal S, "Decreased serum orexin A levels in drug-naive children with attention deficit and hyperactivity disorder", Neurol Sci, 40, pp.593~602 (2019)
26. Blake MG, "Basal forebrain cholinergic system and memory", Curr Top Behav Neurosci, 37, pp.253~273 (2018)
27. Fadel J, "Orexin", hypocretin modulation of the basal forebrain cholinergic system : role in attention, 2010, pp.1314, 112~123
28. Fadel J, "Orexin", hypocretin modulation of the basal forebrain cholinergic system : insights from in vivo microdialysis studies, 2008, pp.90, 156~162
29. Ishibashi M, "Orexin receptor activation generates gamma band input to cholinergic and serotonergic arousal system neurons and drives an intrinsic Ca(2+)-dependent resonance in LDT and PPT cholinergic neurons", Front Neurol, 6, pp.120~ (2015)
30. Stanley EM, "Aging-related deficits in orexin", hypocretin modulation of the septohippocampal cholinergic system, 2012, pp.66, 445~452
31. Piantadosi PT, "Orexin receptor activity in the basal forebrain alters performance on an olfactory discrimination task", Brain Res, 1594, pp.215~222 (2015)
32. Cole S, "Medial prefrontal cortex neural plasticity, orexin receptor 1 signaling, and connectivity with the lateral hypothalamus are necessary in cue-potentiated feeding", J Neurosci, 40, pp.1744~1755 (2020)
33. Duffy CM, "High fat diet increases cognitive decline and neuroinflammation in a model of orexin loss", Neurobiol Learn Mem, 157, pp.41~47 (2019)
34. Huang H, "Prefrontal cortex-projecting glutamatergic thalamic paraventricular nucleus-excited by hypocretin : a feedforward circuit that may enhance cognitive arousal", J Neurophysiol, 95, pp.1656~1668 (2006)
35. Vittoz NM, "Hypocretin", orexin selectively increases dopamine efflux within the prefrontal cortex : involvement of the ventral tegmental area, 2006, pp.31, 384~395
36. Vittoz NM, "Hypocretin", orexin preferentially activates caudomedial ventral tegmental area dopamine neurons, 2008, pp.28, 1629~1640
37. Kessler BA, "Age-related loss of orexin", hypocretin neurons, 2011, pp.178, 82~88
38. Fadel JR, "Food for thought : the role of appetitive peptides in age-related cognitive decline", Ageing Res Rev, 12, pp.764~776 (2013)
39. Villa C, "The synergistic relationship between Alzheimer’s disease and sleep disorders : an update", J Alzheimers Dis, 46, pp.571~580 (2015)
40. Lucey BP, "How amyloid, sleep and memory connect", Nat Neurosci, 18, pp.933~934 (2015)
41. Fronczek R, "Hypocretin(orexin)loss in Alzheimer’s disease", Neurobiol Aging, 33, pp.1642~1650 (2012)
42. Liguori C, "Orexinergic system dysregulation, sleep impairment, and cognitive decline in Alzheimer disease", JAMA Neurol, 71, pp.1498~1505 (2014)
43. Roh JH, "Potential role of orexin and sleep modulation in the pathogenesis of Alzheimer’s disease", J Exp Med, 211, pp.2487~2496 (2014)
44. Schmidt FM, "Cerebrospinal fluid melanin-concentrating hormone(MCH)and hypocretin-1(HCRT-1, orexin-A)in Alzheimer’s disease", PLoS One, 8, pp.e63136~ (2013)
45. Slats D, "Association between hypocretin-1 and amyloid-β42 cerebrospinal fluid levels in Alzheimer’s disease and healthy controls", Curr Alzheimer Res, 9, pp.1119~1125 (2012)
46. Olsson M, "Sleep deprivation and cerebrospinal fluid biomarkers for Alzheimer’s disease", Sleep, 41 (2018)
47. Erik S Musiek, "Sleep, circadian rhythms, and the pathogenesis of Alzheimer Disease", Experimental and Molecular Medicine, 47, pp.1~8 (2015), 생화학분자생물학회
48. Van Egroo M, "Sleep-wake regulation and the hallmarks of the pathogenesis of Alzheimer’s disease", Sleep, 42, pp.pii:zsz017~ (2019)
49. Ma Z, "Orexin signaling regulates both the hippocampal clock and the circadian oscillation of Alzheimer’s disease-risk genes", Sci Rep, 6, pp.36035~ (2016)
50. Liguori C, "Orexin and Alzheimer’s disease", Curr Top Behav Neurosci, 33, pp.305~322 (2017)
51. Kang JE, "Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle", Science, 326, pp.1005~1007 (2009)
52. An H, "Orexin impairs the phagocytosis and degradation of amyloid-beta fibrils by microglial cells", J Alzheimers Dis, 58, pp.253~261 (2017)
53. Holth J, "Sleep in Alzheimer’s disease-beyond amyloid", Neurobiol Sleep Circadian Rhythms, 2, pp.4~14 (2017)
54. Liu Z, "Amyloid β and tau are involved in sleep disorder in Alzheimer’s disease by orexin A and adenosine A(1)receptor", Int J Mol Med, 43, pp.435~442 (2019)
55. Li M, "Orexin-A exacerbates Alzheimer’s disease by inducing mitochondrial impairment", Neurosci Lett, 718, pp.134741~ (2020)
56. Gallone S, "Is HCRTR2 a genetic risk factor for Alzheimer’s disease", Dement Geriatr Cogn Disord, 38, pp.245~253 (2014)
57. Peineau S, "Synaptic plasticity modulation by circulating peptides and metaplasticity : involvement in Alzheimer’s disease", Pharmacol Res, 130, pp.385~401 (2018)
58. Arias-Carrion O, "Depletion of hypocretin", orexin neurons increases cell proliferation in the adult subventricular zone, 2018, pp.17, 106~112
59. Roh J, "Gene Therapy in Neurological Disorders", pp.163~175 (2018), Elsevier, Academic Press
60. Calva CB, "Intranasal administration of orexin peptides : mechanisms and therapeutic potential for age-related cognitive dysfunction", Brain Res, 1731, pp.145921~ (2020)
61. Lleó A, "Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer’s disease continuum in the BIOMARKAPD study", Alzheimers Dement, 15, pp.742~753 (2019)
62. Lin L, "The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin(orexin)receptor 2 gene", Cell, 98, pp.365~376 (1999)
63. Kornum BR, "Narcolepsy with hypocretin", orexin deficiency, infections and autoimmunity of the brain, 2011, pp.21, 897~903
64. Gabelle A, "Reduced brain amyloid burden in elderly patients with narcolepsy type 1", Ann Neurol, 85, pp.74~83 (2019)
65. Jennum PJ, "Cerebrospinal fluid biomarkers of neurodegeneration are decreased or normal in narcolepsy", Sleep, 40 (2017)
66. Hansson O, "CSF biomarkers of Alzheimer’s disease concord with amyloid-βPET and predict clinical progression : a study of fully automated immunoassays in BioFINDER and ADNI cohorts", Alzheimers Dement, 14, pp.1470~1481 (2018)
67. Jiyoung Lyu, "Gender-Specific Incidence and Predictors of Cognitive Impairment among Older Koreans: Findings from a 6-Year Prospective Cohort Study", PSYCHIATRY INVESTIGATION, 13(5), pp.473~479 (2016), 대한신경정신의학회[DOI]
68. Wang C, "Estrogen receptor-α is localized to neurofibrillary tangles in Alzheimer’s disease", Sci Rep, 6, pp.20352~ (2016)
69. Pike CJ, "Sex and the development of Alzheimer’s disease", J Neurosci Res, 95, pp.671~680 (2017)
70. Merlo S, "Estrogen and Alzheimer’s disease : still an attractive topic despite disappointment from early clinical results", Eur J Pharmacol, 817, pp.51~58 (2017)
71. Tansupswatdikul P, "Effects of estrogen therapy on postmenopausal sleep quality regardless of vasomotor symptoms : a randomized trial", Climacteric, 18, pp.198~204 (2015)
72. Joffe H, "Independent contributions of nocturnal hot flashes and sleep disturbance to depression in estrogen-deprived women", J Clin Endocrinol Metab, 101, pp.3847~3855 (2016)
73. Gervais NJ, "Ovarian hormones, sleep and cognition across the adult female lifespan : an integrated perspective", Front Neuroendocrinol, 47, pp.134~153 (2017)
74. McHill AW, "The relationship between estrogen and the decline in delta power during adolescence", Sleep, 40 (2017)
75. El-Sedeek M, "Plasma orexin-A levels in postmenopausal women : possible interaction with estrogen and correlation with cardiovascular risk status", BJOG, 117, pp.488~492 (2010)
76. Macedo AC, "Is sleep disruption a risk factor for Alzheimer’s disease?", J Alzheimers Dis, 58, pp.993~1002 (2017)
77. Minakawa EN, "Sleep disturbance as a potential modifiable risk factor for Alzheimer’s disease", Int J Mol Sci, 20, pp.pii: E803~ (2019)
78. Spira AP, "Sleep disturbance: an emerging opportunity for Alzheimer’s disease prevention?", Int Psychogeriatr, 29, pp.529~531 (2017)
79. Shi L, "Sleep disturbances increase the risk of dementia : a systematic review and meta-analysis", Sleep Med Rev, 40, pp.4~16 (2018)
80. Mander BA, "Sleep: a novel mechanistic pathway, biomarker, and treatment target in the pathology of Alzheimer’s disease?", Trends Neurosci, 39, pp.552~566 (2016)

관련 논문AI추천